Monsanto the disposition of product lines unrelated to agriculture. In 1985, Monsanto acquired G. D. Searle & Company, a life sciences company that focused on pharmaceuticals, agriculture and animal health. In 1993, its Searle division filed a patent application for Celebrex, which in 1998 became the first selective COX‑2 inhibitor to be approved by the U.S. Food and Drug Administration (FDA). Celebrex became a blockbuster drug and was often mentioned as a key reason for Pfizer's acquisition of Monsanto's pharmaceutical business in 2002. In 1994, Monsanto introduced a recombinant version of bovine somatotropin, brand-named Posilac. Monsanto later sold this business to
Monsanto House of the Future February 2008, Disney announced it would conceptually bring back the attraction with a more modern and accessible interior. The $15 million Innoventions Dream Home was a collaboration of the Walt Disney Company, Microsoft, Hewlett-Packard, software maker LifeWare, and homebuilder Taylor Morrison. In 2010, MIT Museum Architecture Curator Gary Van Zante gave a presentation on campus where he showed archived drawings and photographs of the plastic house. The talk, titled "Back to the Future: A 1950s House of the Future", was part of the Cambridge Science Festival. Monsanto House of the Future The Monsanto House of the Future was an attraction